About
About Beijing Science Sun Pharmaceutical Co., Ltd
Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of injections in China. The company offers products for cardiovascular, cerebrovascular, immunomodulation, and nervous systems, and other drugs. It is also involved in raw materials, solid oral preparations, and health products; extraction of traditional Chinese medicine; manufacture of Chinese and Western medicine preparations; research, development, production, and sales of tablets, hard capsules, powders, granules, and active pharmaceutical ingredients; outward investment, technology introduction and exchange, international business development, livestock and poultry production, and research and development of bio-organic fertilizers and bio-feeds. In addition, the company is engaged venture capital; equity investment through private equity funds; technology development, transfer, and services for biological products, pharmaceuticals, diagnostic reagents, and medical devices; biotechnology information consulting; sales of immunoassay reagents and laboratory instruments; research, development and industrialization of human vaccines; investment management and consulting for non-securities businesses, as well as inspection and testing services, consulting services, and health food production. The company was founded in 1999 and is headquartered in Beijing, China.
Research context
Beijing Science Sun Pharmaceutical Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
Beijing Science Sun Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 16.9% below its 200 day moving average.
From a valuation standpoint, the stock is 49.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.9.
Beijing Science Sun Pharmaceutical Co., Ltd's total revenue sank by 2.9% to $303M since the same quarter in the previous year.
Its net income has increased by 17.5% to $26M since the same quarter in the previous year.
Finally, its free cash flow fell by 104.3% to $-1M since the same quarter in the previous year.
Based on the above factors, Beijing Science Sun Pharmaceutical Co., Ltd gets an overall score of 2/5.